Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoo Sato

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Nature Communications|November 10, 2025
Chromatin remodeling enhances MAP3K8 expression in HAM: a key pathogenesis for therapeutic interventionMakoto Nakashima, Kaho Nagai, Naoki Takao, et al.
International Journal of Molecular Medicine|September 30, 2009
Role of Kenae/CCDC125 in cell motility through the deregulation of RhoGTPaseNatsumi Araya, Hitoshi Arimura, Ko-ichi Kawahara, et al.
Molecular Medicine Reports|April 12, 2011
Increased prevalence of group A β-hemolytic streptococcus among an ethnic population in Kyrgyzstan detected by the rapid antigen detection testNazgul A Omurzakova, Yoshihisa Yamano, Tomoo Sato, et al.
Blood|August 12, 2009
Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disordersKazuko Azakami, Tomoo Sato, Natsumi Araya, et al.
International Journal of Clinical Oncology|March 13, 2024
An approach for improvement of the accuracy of cancer gene panel testingKiyomi Imoto, Hiroyuki Yamamoto, Chie Ohkawa, et al.
The Journal of Clinical Investigation|June 25, 2014
HTLV-1 induces a Th1-like state in CD4+CCR4+ T cellsNatsumi Araya, Tomoo Sato, Hitoshi Ando, et al.
Frontiers in Medicine|April 28, 2022
Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated MyelopathyMiyuna Kimura, Junji Yamauchi, Tomoo Sato, et al.
Journal of Neurology|March 2, 2024
Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathyTomoo Sato, Masahiro Nagai, Osamu Watanabe, et al.
Plos One|November 5, 2010
E3 ubiquitin ligase synoviolin is involved in liver fibrogenesisDaisuke Hasegawa, Ryoji Fujii, Naoko Yagishita, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2020
Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesisMisako Nagasaka, Makoto Yamagishi, Naoko Yagishita, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Nature Communications|November 10, 2025
Chromatin remodeling enhances MAP3K8 expression in HAM: a key pathogenesis for therapeutic interventionMakoto Nakashima, Kaho Nagai, Naoki Takao, et al.
International Journal of Molecular Medicine|September 30, 2009
Role of Kenae/CCDC125 in cell motility through the deregulation of RhoGTPaseNatsumi Araya, Hitoshi Arimura, Ko-ichi Kawahara, et al.
Molecular Medicine Reports|April 12, 2011
Increased prevalence of group A β-hemolytic streptococcus among an ethnic population in Kyrgyzstan detected by the rapid antigen detection testNazgul A Omurzakova, Yoshihisa Yamano, Tomoo Sato, et al.
Blood|August 12, 2009
Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disordersKazuko Azakami, Tomoo Sato, Natsumi Araya, et al.
International Journal of Clinical Oncology|March 13, 2024
An approach for improvement of the accuracy of cancer gene panel testingKiyomi Imoto, Hiroyuki Yamamoto, Chie Ohkawa, et al.
The Journal of Clinical Investigation|June 25, 2014
HTLV-1 induces a Th1-like state in CD4+CCR4+ T cellsNatsumi Araya, Tomoo Sato, Hitoshi Ando, et al.
Frontiers in Medicine|April 28, 2022
Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated MyelopathyMiyuna Kimura, Junji Yamauchi, Tomoo Sato, et al.
Journal of Neurology|March 2, 2024
Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathyTomoo Sato, Masahiro Nagai, Osamu Watanabe, et al.
Plos One|November 5, 2010
E3 ubiquitin ligase synoviolin is involved in liver fibrogenesisDaisuke Hasegawa, Ryoji Fujii, Naoko Yagishita, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 2020
Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesisMisako Nagasaka, Makoto Yamagishi, Naoko Yagishita, et al.
Pageof 9